METASTATIC SOLID TUMOR
Clinical trials for METASTATIC SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOLID TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of new Cancer-Fighting antibody begins
Disease control TerminatedThis is an early-stage study to test the safety and find the right dose of a new drug called BGB-B3227 for people with advanced or metastatic solid tumors. The drug will be tested both by itself and in combination with another cancer drug, tislelizumab. The main goals are to see …
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: BeiGene • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
Terminated trial tests new drug duo for Tough-to-Treat cancers
Disease control TerminatedThis study tested a new drug, PRT3789, combined with an existing immunotherapy (pembrolizumab) for people with advanced or spreading cancers that have a specific genetic change called a SMARCA4 mutation. The goal was to see if this combination was safe and could shrink or control…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE2 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New pill targets genetic weakness in advanced cancers
Disease control TerminatedThis early-stage study tested a new oral drug called PRT7732 in people with advanced or metastatic solid tumors that have a specific genetic change (SMARCA4 mutation). The main goals were to find a safe dose, see how the body processes the drug, and look for early signs that it m…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC
-
New drug injected into tumors to wake up immune system against cancer
Disease control TerminatedThis early-phase study tested a new experimental drug designed to stimulate the body's immune system to fight cancer. The drug was injected directly into tumors in adults with advanced solid cancers that had stopped responding to standard treatments. Researchers aimed to find a s…
Matched conditions: METASTATIC SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC